Loss of Rb1 Associated With the Onset of Acquired Resistance to Trastuzumab Deruxtecan in TP53-/HER2-Mutated Non-Small-Cell Lung Cancer: Case Series

被引：1
|
作者：
Gupta, Ashish [1 ,4 ]
Jatwani, Karan [1 ]
Gupta, Kush [2 ]
Qiu, Jingxin [3 ]
Dy, Grace K. [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Dept Med, Elm & Carlton St, Buffalo, NY USA
[2] Univ Massachusetts, Dept Med, Med Sch Baystate, Springfield, MA USA
[3] Roswell Park Comprehens Canc Ctr, Dept Pathol, Buffalo, NY USA
[4] Roswell Park Comprehens Canc Ctr, Dept Med, Elm & Carlton St, Buffalo, NY 14203 USA
来源：
JCO PRECISION ONCOLOGY | 2023年 / 7卷
关键词：
D O I：
10.1200/PO.22.00476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC)
    Feng, J.
    Hueniken, K.
    Fan, Z. J.
    Corke, L.
    Leighl, N. B.
    Liu, G.
    Bradbury, P. A.
    Sacher, A.
    Eng, L.
    Stockley, T.
    Tsao, M. S.
    Shepherd, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S343 - S344
  • [2] Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
    Li, Bob T.
    Smit, Egbert F.
    Goto, Yasushi
    Nakagawa, Kazuhiko
    Udagawa, Hibiki
    Mazieres, Julien
    Nagasaka, Misako
    Bazhenova, Lyudmila
    Saltos, Andreas N.
    Felip, Enriqueta
    Pacheco, Jose M.
    Perol, Maurice
    Paz-Ares, Luis
    Saxena, Kapil
    Shiga, Ryota
    Cheng, Yingkai
    Acharyya, Suddhasatta
    Vitazka, Patrik
    Shahidi, Javad
    Planchard, David
    Janne, Pasi A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (03): : 241 - 251
  • [3] Trastuzumab Deruxtecan in HER2-Mutated Metastatic Non-Small Cell Lung Cancer (NSCLC): Interim Results of DESTINY-Lung01
    Smit, E.
    Nakagawa, K.
    Nagasaka, M.
    Felip, E.
    Goto, Y.
    Li, B.
    Pacheco, J.
    Murakami, H.
    Barlesi, F.
    Saltos, A.
    Perol, M.
    Udagawa, H.
    Saxena, K.
    Shiga, R.
    Guevara, F.
    Acharyya, S.
    Shahidi, J.
    Planchard, D.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S173 - S173
  • [4] A Case of Metastatic HER2-Amplified Non-Small-Cell Lung Cancer (NSCLC) Treated with Trastuzumab Deruxtecan
    Yun, K.
    Bazhenova, L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E38 - E38
  • [5] CNS activity of trastuzumab deruxtecan in HER2-expressing non-small-cell lung cancer
    Lazaratos, Anna-Maria
    Petrecca, Kevin
    Guiot, Marie-Christine
    Dankner, Matthew
    Jerzak, Katarzyna J.
    LANCET ONCOLOGY, 2024, 25 (07): : e282 - e282
  • [6] Metastatic HER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
    Yun, Karen M.
    Bazhenova, Lyudmila
    BMJ CASE REPORTS, 2023, 16 (05)
  • [7] Prognostic effects of TP53 variants co-occuring in patients with HER2-mutated non-small cell lung cancer (NSCLC)
    Feng, Jamie
    Hueniken, Katrina
    Fan, Zhen
    Corke, Lucy
    Leighl, Natasha B.
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Sacher, Adrian G.
    Eng, Lawson
    Stockley, Tracy
    Tsao, Ming Sound
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] DESTINY-Lung01 Trial Investigators Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer
    Sharayah, Ahmad
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (06) : 749 - 750
  • [9] Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non-small-cell Lung Cancer
    Al-Obeidi, Ebaa
    Li, Tianhong
    Kelly, Karen
    CLINICAL LUNG CANCER, 2020, 21 (01) : E15 - E20
  • [10] Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01.
    Smit, Egbert F.
    Nakagawa, Kazuhiko
    Nagasaka, Misako
    Felip, Enriqueta
    Goto, Yasushi
    Li, Bob T.
    Pacheco, Jose Maria
    Murakami, Haruyasu
    Barlesi, Fabrice
    Saltos, Andreas Nicholas
    Perol, Maurice
    Udagawa, Hibiki
    Saxena, Kapil
    Shiga, Ryota
    Guevara, Ferdinand M.
    Acharyya, Suddhasatta
    Shahidi, Javad
    Planchard, David
    Janne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345